Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of ...

It looks like SoftBank's Vision Fund 2 is coming back strong. In the last nearly two quarters, the fund has participated in ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

TAIPEI, Taiwan I March 17, 2025 I TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 long-acting dual bNAb regimen for HIV ...

DES MOINES, Iowa, March 17, 2025 /PRNewswire/ -- Biospace.com, the leading life science news and careers site, is celebrating its 30 th anniversary, marking three decades of innovation, industry ...

Third Generation Sequencing Market 2025 BURLINGAME, CA, UNITED STATES, March 17, 2025 /EINPresswire / -- The Global Third Generation Sequencin ...

Global Bispecific Antibodies market size to surpass US$ 50 Billion By 2030 Says Kuick Research Delhi, March 17, 2025 (GLOBE ...